Transforming drug delivery for women
Supporting fertility, pregnancy, a healthy vaginal microbiome and other gynaecological conditions
— As featured in —
“Callavid will be unbelievably popular with miscarriage patients as pessary leakage is the most frequent complaint, causing significant anxiety. The benefits of reducing psychological trauma, anxiety and depression are badly needed.”
The vagina’s huge medical potential has gone untapped, but not for much longer
“Calla Lily has developed a new leak-free vaginal drug delivery platform. It's simple to use (essential when patients have to administer medications themselves) and also helps to alleviate dosage anxiety and other stresses”
Drug Discovery News: CLCC joins $50m program targeting antibiotic resistanceForbes features CLCCFierce covers CLCC collaboration with MerckBBC News coverage of Callavid®CLCC awarded £1m NIHR funding to address threatened miscarriageWhy Intravaginal Progesterone Therapy is a Smart Choice and a Smart Investment🇯🇵 Japanese delegation visits Calla Lily Labs
“Thanks to NICE’s new miscarriage management guidance, for the first time we now have a recommended medication to prescribe to help reduce the incidence of miscarriages: vaginal micronised progesterone. This new device addresses patients’ issues of leakage and inconvenience previously associated with vaginally-delivered progesterone.”
